Frederick D Goldman Selected Research

Frederick D Goldman Research Topics

Disease

8	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 11/2023 - 06/2007
5	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2023 - 07/2014
4	Primary Immunodeficiency Diseases 01/2023 - 07/2014
3	Premature Aging 11/2023 - 03/2011
3	Neoplasms (Cancer) 01/2022 - 02/2003
2	Wiskott-Aldrich Syndrome 04/2024 - 01/2020
2	Hemorrhage 01/2021 - 01/2019
2	Bronchiolitis Obliterans Syndrome 01/2012 - 12/2011
1	Inflammation (Inflammations) 11/2023
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2022
1	Infections 01/2022
1	Intellectual Disability (Idiocy) 01/2021
1	Craniofacial Abnormalities 01/2021
1	Anemia 01/2021
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2021
1	Neutropenia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Hepatopulmonary Syndrome 01/2019
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2019
1	Cytopenia 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Hypersensitivity (Allergy) 01/2016
1	Bone Marrow Failure Disorders 01/2016
1	Aplastic Anemia (Anemia, Hypoplastic) 07/2011
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2010
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2010
1	Congenital Bone Marrow Failure Syndromes 06/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2007
1	Aspergillosis 07/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2005
1	Leukemia 03/2005
1	Juvenile Myelomonocytic Leukemia 03/2005
1	Medulloblastoma 02/2003
1	Autoimmune Lymphoproliferative Syndrome 07/2002

Drug/Important Bio-Agent (IBA)

6	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2023 - 06/2007
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2023
1	Adenosine DeaminaseIBA 01/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	tert-butylserineIBA 01/2019
1	treosulfanIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Cytotoxins (Cytolysins)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 12/2012
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2012
1	CytokinesIBA 12/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2011
1	Telomere-Binding ProteinsIBA 03/2011
1	telomerase RNA (bTR)IBA 03/2010
1	Immunoglobulins (Immunoglobulin)IBA 01/2010
1	AndrogensIBA 03/2007
1	Voriconazole (Vfend)FDA LinkGeneric 07/2006
1	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2005
1	Clofarabine (Clolar)FDA Link 03/2005
1	tipifarnib (R115777)IBA 03/2005
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2002
1	fas Receptor (CD95 Antigen)IBA 07/2002

Therapy/Procedure

6	Cell Transplantation 01/2023 - 08/2013
4	Therapeutics 01/2022 - 07/2006
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018 - 10/2005
3	Transplantation 07/2014 - 07/2011
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Homologous Transplantation 08/2013
1	Drug Therapy (Chemotherapy) 03/2007
1	Adjuvant Chemotherapy 02/2003
1	Duration of Therapy 02/2003
1	Radiotherapy 02/2003
1	Craniospinal Irradiation 02/2003